The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia

Bone Marrow Transplantation

Volumn 45, Issue 11, 2010, Pages 1618-1624

  Littera, R ^a   Orr, N ^b   Vacca, A ^a   Bertaina, A ^c   Caocci, G ^a   Mulargia, M ^a   Giardini, C ^d   Piras, E ^a   Mastronuzzi, A ^c   Vinti, L ^c   Orru S ^b   Locatelli, F ^c   Carcassi, C ^a,b   Nasa, G L ^a,b  

^a Binaghi Hospital   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d SAN SALVATORE HOSPITAL   (Italy)

Author keywords

acute GVHD; haematopoietic SCT; KIR haplotypes; natural killer cells; thalassaemia

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; METHOTREXATE; THIOTEPA; THYMOCYTE ANTIBODY; TREOSULFAN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BETA THALASSEMIA; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; MYELOABLATIVE CONDITIONING; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENOTYPE; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KILLER CELLS, NATURAL; MALE; RECEPTORS, KIR; RETROSPECTIVE STUDIES; THALASSEMIA; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78149470253     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.24     Document Type: Article

References (28)

1. Moretta A, Locatelli F, Moretta L. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias. Immunol Rev 2008; 224: 58-69.
2. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001; 15: 363-374. (Pubitemid 32907384)
3. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 2006; 7: 277-300. (Pubitemid 44627931)
4. Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, Markel G et al. MHC Class-I independent recognition of NK-activating receptor KIR2DS4. J Immunol 2004; 173: 1819-1825. (Pubitemid 38971615)
5. Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry and the Dutch registry. Biol Blood Marrow Transplant 2006; 12: 876-884. (Pubitemid 44070674)
6. Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103: 1521-1526. (Pubitemid 38168673)
7. Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 2005; 105: 4878-4884. (Pubitemid 40807317)
8. La Nasa G, Argiolu F, Giardini C, Pession A, Fagioli F, Caocci G et al. Unrelated bone marrow transplantation for thalassemia patients. The experience of the Italian Bone Marrow Transplant Group. Ann N Y Acad Sci 2005; 1054: 186-195. (Pubitemid 43031024)
9. Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975; 292: 895-902.
10. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753-763. (Pubitemid 28064889)
11. Gagne K, Brizard G, Gueglio B, Milpied N, Herry P, Bonneville F et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 2002; 63: 271-280. (Pubitemid 34303697)
12. Lucarelli G, Giardini C, Angelucci E. Bone marrow trans-plantation in thalassemia. In: Winter JN (ed). Blood Stem Cell Transplantation. Kluwer Academic: Boston, MA, 1997, pp 305-315.
13. Zino E, Frumento G, Marktel S, Sormani MP, Ficara F, Di Terlizzi S et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hemato-logic stem cell transplantation. Blood 2004; 103: 1417-1424. (Pubitemid 38168657)
14. Fleischhauer K, Locatelli F, Zecca M, Orofino MG, Giardini C, De Stefano P et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood 2006; 107: 2984-2992.
15. Klein JP, Rizzo JD, Zhang MJ, Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants, Part 2: regression modeling. Bone Marrow Transplant 2001; 28: 1001-1011. (Pubitemid 34030645)
16. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002; 54: 221-229. (Pubitemid 34824132)
17. Bontadini A, Testi M, Cuccia MC, Martinetti M, Carcassi C, Chiesa A et al. Distribution of killer cell immunoglobulin-like receptors genes in the Italian Caucasian population. J Transl Med 2006; 4: 44. (Pubitemid 44742621)
18. Norman PJ, Stephens HA, Verity DH, Chandanayingyong D, Vaughan RW. Distribution of natural killer cell immunoglo-bulin-like receptor sequences in three ethnic groups. Immuno-genetics 2001; 52: 195. (Pubitemid 32142806)
19. Ludajic K, Balavarca Y, Bickeboller H, Rosenmayr A, Fae I, Fischer GF et al. KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation. Bone Marrow Trans-plant 2009; 44: 97-103.
20. Yawata M, Yawata N, McQueen KL, Cheng NW, Guethlein LA, Rajalingam R et al. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics 2002; 54: 543-550. (Pubitemid 35435512)
21. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J et al. Prevention of graft versus host disease by inactivation ofhost antigen-presenting cells. Science 1999; 285: 412-415. (Pubitemid 29343964)
22. Zaia JA, Sun JY, Gallez-Hawkins GM, Thao L, Oki A, Lacey SF et al. The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplant-ation. BiolBloodMarrow Transplant 2009; 15: 315-325.
23. Broers AE, van Der Holt R, van Esser JW, Gratama JW, Henzen-Logmans S, Kuenen-Boumeester V et al. Increased transplant-related morbidity and mortality in CMV-seroposi-tive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplant-ation. Blood 2000; 95: 2240-2245. (Pubitemid 30167720)
24. Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K et al. Role of Natural Killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333-339. (Pubitemid 29300166)
25. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor Natural Killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100. (Pubitemid 34229476)
26. Ruggeri L, Capanni M, Mancusi A, Martelli MF, Velardi A. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. Transpl Immunol 2005; 14: 203-206. (Pubitemid 40848526)
27. La Nasa G, Littera R, Locatelli F, Giardini C, Ventrella A, Mulargia M et al. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients. Biol Blood Marrow Transplant 2007; 13: 1358-1368. (Pubitemid 47591391)
28. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC et al. Survival and complica-tions in patients with thalassemia major treated with transfu-sion and deferoxamine. Haematologica 2004; 89: 1187-1193. (Pubitemid 39390442)